Ignite Creation Date:
2025-12-25 @ 12:40 AM
Ignite Modification Date:
2026-01-02 @ 1:23 PM
Study NCT ID:
NCT00457067
Status:
COMPLETED
Last Update Posted:
2017-07-02
First Post:
2007-04-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Injected Ranibizumab to Treat Macular Telangiectasia With New Blood Vessel Formation
Sponsor:
National Eye Institute (NEI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
070095
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None